The experienced guide for cell & gene therapy manufacturing

SCTbio is the leader in services, development and cGMP production of cell-based therapies and retroviruses vectors, with the experience to be your high-quality and accessible CDMO partner. SCTbio is supported by PPF Group.

What can the right cell therapy CDMO partner do for you?

What sets SCTbio apart is the people. Unlike large CDMOs, SCTbio’s staff is intensely client-focused, with the forethought to ask the right questions, the wisdom to listen carefully to a partner’s needs, and the experience to offer innovative solutions.

We also have specialized expertise in cell-based products, including dendritic cell therapeutics and other genetically modified constructs such as CAR-T, as well as lentiviral and gammaretroviral vector production used for the modification of the cellular products.


SCTbio delivers the highest quality collaboration through a range of services ensuring GMP compliance for the full life cycle of drug development, that include technology transfers, process development, clinical manufacturing services, fill & finish, quality control, QA/QP release, storage and logistics.

Cell and gene therapy researchers working in SCTbio’s GMP laboratory.
Lab technician working at a microplate reader in SCTbio’s cell and gene facility.
Lab employees in full personal protective equipment handling cell and gene therapy products.
Employee loading up a cardboard box of biologic samples at SCTbio’s contract manufacturing facility.
Cell and gene therapy samples in a box.
Calculator and office equipment on some paper at SCTbio offices in Prague.

Unique Global Network of Apheresis Centers

SCTbio has established close cooperation with Apheresis Centers in Europe and the USA and can provide support in setting up the appropriate procedures within a network of 150 qualified and regularly monitored cell-collection sites.

Worldwide map showing the locations of SCTbio’s 150 qualified and regularly monitored Apheresis Centres.